|
FKBP2 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.982400E-04 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.059900E-03 |
| Normal-vs-Stage2 |
7.478600E-01 |
| Normal-vs-Stage3 |
4.47260000002725E-06 |
| Normal-vs-Stage4 |
2.11369999999489E-05 |
| Stage1-vs-Stage2 |
4.916000E-02 |
| Stage1-vs-Stage3 |
2.560000E-02 |
| Stage1-vs-Stage4 |
1.193950E-02 |
| Stage2-vs-Stage3 |
3.041700E-03 |
| Stage2-vs-Stage4 |
1.381980E-03 |
| Stage3-vs-Stage4 |
5.290000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
9.80990000000181E-05 |
| Normal-vs-AfricanAmerican |
5.659700E-03 |
| Normal-vs-Asian |
3.262700E-03 |
| Caucasian-vs-AfricanAmerican |
5.964400E-01 |
| Caucasian-vs-Asian |
9.373800E-01 |
| AfricanAmerican-vs-Asian |
5.738400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.876080E-03 |
| Normal-vs-Female |
5.787600E-04 |
| Male-vs-Female |
7.655400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.083000E-03 |
| Normal-vs-Age(41-60Yrs) |
1.773840E-04 |
| Normal-vs-Age(61-80Yrs) |
1.635050E-03 |
| Normal-vs-Age(81-100Yrs) |
4.821800E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.700400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.167000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.630200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.419400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.111600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.243400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.037300E-04 |
| Classical-VS-Follicular |
4.43379999381932E-10 |
| Classical-VS-Other |
5.767800E-01 |
| Classical-VS-Normal |
4.39220000036933E-07 |
| Tall-VS-Follicular |
1.86994864037615E-12 |
| Tall-VS-Other |
1.100990E-01 |
| Tall-VS-Normal |
2.34289998513049E-09 |
| Follicular-VS-Other |
1.096210E-01 |
| Follicular-VS-Normal |
3.926600E-01 |
| Other-VS-Normal |
2.042200E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.075700E-02 |
| Normal-vs-N1 |
3.911900E-02 |
| N0-vs-N1 |
3.833800E-01 |
|
|
